Beijing Hotgen Biotech Co., Ltd. (SHA:688068)

China flag China · Delayed Price · Currency is CNY
190.52
-21.47 (-10.13%)
Aug 28, 2025, 9:45 AM CST
-10.13%
Market Cap18.83B
Revenue (ttm)488.02M
Net Income (ttm)-220.07M
Shares Out88.83M
EPS (ttm)-2.33
PE Ration/a
Forward PEn/a
Dividend0.20 (0.08%)
Ex-Dividend Daten/a
Volume1,382,650
Average Volume2,653,312
Open204.56
Previous Close211.99
Day's Range190.01 - 207.19
52-Week Range22.94 - 262.22
Beta1.67
RSI47.40
Earnings DateAug 30, 2025

About Beijing Hotgen Biotech

Beijing Hotgen Biotech Co., Ltd. engages in the research, development, manufacture, and sale of medical and public safety inspection products of in-vitro diagnostic products in the field of biomedicine. It offers drug detection, CDC, Up-conversion luminescence technology, colloidal gold, CLIA, sugar capture, microfluidic, and gene detection products for testing of intestinal microorganisms, gastrointestinal foodborne infections, insect-borne diseases, respiratory pathogens, infectious diseases, Ebola virus antigen, biological warfare agents, mi... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2005
Employees 903
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688068
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.